The Global Cancer Immunotherapy Market achieved a valuation of $121.2 Billion in 2023 and is anticipated to exceed $245.37 ...

Researchers discovered that gut microbiota-derived hexa-acylated LPS enhances the effectiveness of anti-PD-1 cancer ...

Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet promising study from Memorial Sloan Kettering Cancer Center.

This relationship is vital for the success of immunotherapy-based treatments which, despite their curative potential, currently only work in between 20 and 40% of patients," explains Dr. Anna ...

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

Source: Mr. Damodaran at the Stern School of Business at NYU.Current ownership breakdown: Insiders 79%; Independent Board Members ...

Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a ...

The research uncovers key genetic mutations that affect cancer treatment responses and develops a predictive tool for ...

The annual BioTech Breakthrough Awards program evaluates top companies, solutions, and products in the global life sciences and biotechnology markets. This year's program attracted thousands of ...

Immunotherapy revolutionises cancer treatment by harnessing the immune system, offering targeted therapy with fewer side ...

While immunotherapy approaches to cancer treatment have had monumental benefits for cancer care, dichotomy in cohorts of ...